Organization Overview
Alternative names
atorvastatin (lipitor) (5 trials)
bevacizumab (avastin) (1 trial)
candesartan (atacand) (1 trial)
carboplatin (paraplatin) (2 trials)
fluorouracil (efudex) (2 trials)
hepatitis a vaccine, inactivated (vaqta) (3 trials)
Alzheimer Disease (Phase 1)
Anorexia (Phase 1)
Aortic Valve Stenosis (Phase 4)
Cachexia (Phase 1)
Candidiasis (Phase 1)
Carcinoma (Phase 3)
Cerebral Infarction (Phase 4)
Constriction, Pathologic (Phase 4)
Coronary Artery Disease (Phase 4)
Coronary Disease (Phase 4)
Dermatomycoses (Phase 1)
Diphtheria (Phase 3)
Dyslipidemias (Phase 3)
Encephalitis (Phase 4)
Encephalitis, Japanese (Phase 4)
Endometrial Neoplasms (Phase 2)
Esophagitis (Phase 3)
Essential Hypertension (Phase 3)
Fallopian Tube Neoplasms (Phase 3)
Hepatitis (Phase 3)
Hepatitis A (Phase 3)
Histoplasmosis (Phase 1)
Hyperlipidemias (Phase 1)
Hyperplasia (Phase 1)
Hypertension (Phase 4)
Inflammation (Phase 4)
Ischemia (Phase 4)
Kidney Diseases (Phase 3)
Leiomyoma (Phase 1)
Leukemia (Phase 1)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 1)
Leukemia, Lymphoid (Phase 1)
Liver Diseases (Phase 1)
Lymphoma (Phase 2)
Lymphoma, B-Cell (Phase 1)
Lymphoma, Large B-Cell, Diffuse (Phase 1)
Lymphoma, Non-Hodgkin (Phase 2)
Lymphoma, T-Cell, Peripheral (Phase 1)
Metabolic Syndrome (Phase 4)
Mycoses (Phase 1)
Myofibroma (Phase 1)
Ovarian Neoplasms (Phase 3)
Peptic Ulcer (Phase 1)
Peripheral Nervous System Diseases (Phase 3)
Peritoneal Neoplasms (Phase 2)
Plaque, Atherosclerotic (Phase 4)
Poliomyelitis (Phase 3)
Prostatic Hyperplasia (Phase 1)
Renal Insufficiency (Phase 1)
Renal Insufficiency, Chronic (Phase 3)
Sepsis (Phase 2)
Shock (Phase 2)
Shock, Septic (Phase 2)
Stomach Neoplasms (Phase 3)
Stomach Ulcer (Phase 1)
Stroke (Phase 4)
Syndrome (Phase 4)
Tetanus (Phase 3)
Tetany (Phase 3)
Toxemia (Phase 2)
Urinary Bladder, Overactive (Phase 1)
Uterine Cervical Neoplasms (Phase 3)
Waldenstrom Macroglobulinemia (Phase 1)
Whooping Cough (Phase 3)